Venkys (India) Ltd Q2 FY26 Results & Concall Highlights: Revenue, Margins & Order Book

Published 28 May 2026 | Food Products | Market Cap: ₹2.2K Cr

Animal Health segment is expected to grow steadily, aiming to cross INR 370-380 crores this year with new product lines planned, indicating stable and consistent growth. Poultry segment losses are significant currently but improvement expected in second half of FY '26 due to better realizations and demand post-festive season.

From Venkys (India) Ltd's Q2 FY26 earnings-call transcript · updated 23 Aug 2026.

Price

1,507

Market Cap

₹2.2K Cr

P/E Ratio

12.4

How does Venkys (India) Ltd rank in Food Products?

Compare Venkys (India) Ltd against every Food Products company this quarter on revenue, margins and earnings-call signals.

View Food Products leaderboard →

Venkys (India) Ltd — Quarterly revenue & net profit

Revenue Net Profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹1.1K Cr, net profit ₹101 Cr.

Full financials →

📊 Revenue & Sales Performance

  • Animal Health segment is expected to grow steadily, aiming to cross INR 370-380 crores this year with new product lines planned, indicating stable and consistent growth.
  • Poultry segment volume utilization currently at 67% (broiler) and 75% (layer), with capacity available to increase production by about 25-33% if demand improves.
  • Expansion plans are underway for the SPF segment post-rainy season and possible layer segment expansion in FY 27-28, indicating future capacity increase.
  • Poultry prices expected to improve from January to June, supporting volume and revenue growth.
  • Raw material costs expected to stabilize with possible positive impact on margins in coming quarters.
  • Overall volumes and revenue growth are tied closely to market demand, seasonal factors, and price realizations; improvement anticipated in the second half of FY 26 and beyond.

📈 Profitability & Margins

- Poultry segment losses are significant currently but improvement expected in second half of FY '26 due to better realizations and demand post-festive season. - Raw material prices (maize, soya) have declined below MSP, expected to positively impact cost of production, reflected mainly in Q3 FY '26 and beyond. - Animal Health segment is stable and growing consistently with expected revenue crossing INR 370-380 crores this financial year, with new products launching to support growth. - Capacity utilization in broiler (67%), layer (75%), feed mill (52%), SPF (50%), and oilseed (50-55%) has room for growth if demand improves. - Expansion plans underway in SPF segment post-rainy season; layer segment expansion planned for FY '27-28. - Management hopeful of covering losses and turning profitable as market conditions improve. - No specific numeric forecast on EPS or operating profits was provided, but optimistic tone on recovery and growth across segments. Overall, earnings growth is expected to pick up from H2 FY '26 onwards driven by improved realizations, raw material cost benefits, and capacity utilization.

🏗️ Capital Expenditure Plans

  • Expansion plans underway in the SPF (Specific Pathogen Free) segment, with capacity buildup expected to start after the rainy season.
  • Capacity expansion has already taken place in the Animal Health Products (AHP) segment.
  • Plans for poultry segment expansion, particularly in the layer segment, are being considered for fiscal years 2027-28.
  • Current capacity and numbers are deemed sufficient to meet market requirements for now.
  • No specific mention of new strategic investments beyond these expansions was provided.

💰 Fundraising & Capital Structure

  • There is no mention of any current or planned fundraising through debt or equity in the transcript.
  • The management did not discuss raising capital or issuing new shares during the Q2 FY '26 earnings call.
  • Expansion plans discussed are primarily focused on capacity buildup in SPF, AHP, and layer segments without reference to new funding.
  • No specific updates on debt refinancing or equity dilution were provided.
  • For any unanswered questions, including fundraising plans, investors are encouraged to email the company’s investor relations.

📋 Order Book & Pipeline

The transcript does not explicitly mention the current or expected order book or pending orders details. However, from the management comments on capacity utilization and demand outlook: - Broiler segment utilization is at 67%, with room to increase by about one-third if demand arises. - Layer segment is at 75% utilization, with potential to utilize remaining capacity especially during the January to July season. - SPF segment utilization is at 50%, with capacity left if good orders are received. - Feed mill capacity utilization is 52%, and oilseed segment capacity utilization is around 50-55%. - Management expects an improved demand scenario from October last week onwards and hopes for better realization and packing production. - Capacity expansions are planned in SPF (ongoing) and layer segment (planned for FY '27-'28) but not immediately. - Industry operators take quick calls between keeping farms empty or restarting based on demand and price signals. No specific numeric order book or backlog values were disclosed.

Key Metrics

Frequently Asked Questions

What were Venkys (India) Ltd Q2 FY26 results?

Animal Health segment is expected to grow steadily, aiming to cross INR 370-380 crores this year with new product lines planned, indicating stable and consistent growth. Poultry segment losses are significant currently but improvement expected in second half of FY '26 due to better realizations and demand post-festive season.

What is Venkys (India) Ltd share price analysis?

Venkys (India) Ltd currently shows a neutral. The stock trades at a P/E of 12.4 with a market cap of ₹2,153 Cr. Investors should review the full earnings analysis for detailed insights.

Is Venkys (India) Ltd planning capital expenditure?

Expansion plans underway in the SPF (Specific Pathogen Free) segment, with capacity buildup expected to start after the rainy season.

Keep Venkys (India) Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.

What Venkys (India) Ltd's management said in earlier quarters

Others in Food Products this season

  • DSM Fresh (Q2 FY26)

    Trade receivables stand at INR 20 crores; however, the portion older than six months is not specified and will be shared offline. Key concall takeaways from…

  • Nakoda Group (Q2 FY26)

    Export markets continue to contribute around 20-25% of annual revenue with presence in over 25 countries. Key concall takeaways from Nakoda Group of Industries…

  • Orkla India (Q2 FY26)

    Volume growth in H1 FY 2026 was 8%, the highest in the last three financial years. Key concall takeaways from Orkla India Ltd's Q2 FY26 earnings call — and how…

  • Hoac Foods (Q2 FY26)

    ft.) will increase capacity, potentially generating around INR 100 crores turnover at full capacity (Page 7). Key concall takeaways from Hoac Foods India Ltd's…